Anders Lindblad
-
- Cystic Fibrosis Research Advances 54
- Neonatal Respiratory Health Research 29
- Tracheal and airway disorders 15
- Chronic Obstructive Pulmonary Disease (COPD) Research 13
- Respiratory Support and Mechanisms 8
- Inhalation and Respiratory Drug Delivery 6
- Epidemiology top 5%
- Microbiology top 10%
- Small Animals top 5%
- Speech and Hearing top 5%
-
- Vitamin D Research Studies 4
-
- Pediatric Hepatobiliary Diseases and Treatments 4
Anders Lindblad
78 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 110
- Pulmonary and Respiratory Medicine 2.1k
- Epidemiology 559
- Microbiology 12
- Small Animals 111
- Speech and Hearing 101
Countries citing papers authored by Anders Lindblad
This map shows the geographic impact of Anders Lindblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Lindblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Lindblad more than expected).
Fields of papers citing papers by Anders Lindblad
This network shows the impact of papers produced by Anders Lindblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Lindblad. The network helps show where Anders Lindblad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Lindblad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 14 | |
| 10 | 2017 | 24 | |
| 11 | 2017 | 42 | |
| 12 | 2015 | 86 | |
| 13 | 2014 | 14 | |
| 14 | 2013 | 149 | |
| 15 | 2012 | 3 | |
| 16 | 2010 | 47 | |
| 17 | 2006 | 24 | |
| 18 | 2002 | 144 | |
| 19 | 2001 | 21 | |
| 20 | 1987 | 49 |
About Anders Lindblad
Anders Lindblad is a scholar working on Pulmonary and Respiratory Medicine, Microbiology, Molecular Medicine, Emergency Medical Services and Infectious Diseases, having authored 80 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (54 papers), Neonatal Respiratory Health Research (29 papers), Tracheal and airway disorders (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Respiratory Support and Mechanisms (8 papers), Inhalation and Respiratory Drug Delivery (6 papers), Vitamin D Research Studies (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Epidemiology (559 citations), Microbiology (12 citations), Small Animals (111 citations) and Speech and Hearing (101 citations). Anders Lindblad has collaborated with scholars based in Sweden, Australia and Denmark. Frequent co-authors include Per Gustafsson, Birgitta Strandvik, Hans Glaumann, P. Aurora, Harm A.W.M. Tiddens, Pim A. de Jong, Marita Gilljam, Bodil Jönsson, Paul D. Robinson and Christina Welinder‐Olsson. Their work appears in journals such as Journal of Cystic Fibrosis, Acta Paediatrica, Journal of Applied Physiology, European Respiratory Journal and Pediatric Pulmonology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.